Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 20, 2021, 9:41 a.m.

/zigman2/quotes/209129655/composite

$

11.50

Change

-0.67 -5.51%

Volume

Volume 1.62m

Real time quotes

/zigman2/quotes/209129655/composite

Previous close

$ 12.17

$ 11.50

Change

-0.67 -5.51%

Day low

Day high

$11.41

$11.77

Open

52 week low

52 week high

$4.41

$67.00

Open

Company Description

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products...

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in New York, NY.

Valuation

Price to Sales Ratio

8.93

Price to Book Ratio

1.70

Enterprise Value to Sales

9.82

Total Debt to Enterprise Value

0.19

Efficiency

Revenue/Employee

244,326.00

Income Per Employee

-174,962.00

Receivables Turnover

7.73

Total Asset Turnover

0.15

Liquidity

Current Ratio

2.20

Quick Ratio

1.56

Cash Ratio

1.22

Profitability

Gross Margin

17.14

Operating Margin

-13.36

Pretax Margin

-67.15

Net Margin

-71.61

Return on Assets

-10.62

Return on Equity

-15.49

Return on Total Capital

-2.23

Return on Invested Capital

-12.05

Capital Structure

Total Debt to Total Equity

21.05

Total Debt to Total Capital

17.39

Total Debt to Total Assets

15.58

Long-Term Debt to Equity

19.94

Long-Term Debt to Total Capital

16.47

Officers and Executives

Name Age Officer Since Title
Mr. Irwin David Simon 61 2021 Chairman & Chief Executive Officer
Mr. Carl A. Merton - 2021 Chief Financial Officer
Mr. Lloyd Brathwaite - 2021 Chief Information Officer
Dr. Joshua Eades - 2014 Chief Science Officer
Dr. Catherine Jacobson - 2018 Vice President-Regulatory & Medical Affairs

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/19/2021 Irwin David Simon
President and CEO; Director
120,291   Derivative/Non-derivative trans. at $12.68 per share. 1,525,289
08/19/2021 Irwin David Simon
President and CEO; Director
36,088   Derivative/Non-derivative trans. at $12.68 per share. 457,595
08/19/2021 Irwin David Simon
President and CEO; Director
89,495   Derivative/Non-derivative trans. at $12.68 per share. 1,134,796
08/19/2021 James R. Meiers
Head of Canada
7,299   Derivative/Non-derivative trans. at $12.68 per share. 92,551
08/19/2021 James R. Meiers
Head of Canada
7,633   Derivative/Non-derivative trans. at $12.68 per share. 96,786
08/19/2021 Carl A. Merton
Chief Financial Officer
50,247   Derivative/Non-derivative trans. at $12.68 per share. 637,131
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
8,925   Derivative/Non-derivative trans. at $12.68 per share. 113,169
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
10,505   Derivative/Non-derivative trans. at $12.68 per share. 133,203
08/19/2021 Irwin David Simon
President and CEO; Director
242,277   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Irwin David Simon
President and CEO; Director
72,683   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Irwin David Simon
President and CEO; Director
180,251   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 James R. Meiers
Head of Canada
31,125   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 James R. Meiers
Head of Canada
32,548   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Carl A. Merton
Chief Financial Officer
96,628   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
26,444   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
31,125   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 Irwin David Simon
President and CEO; Director
90,126   Derivative/Non-derivative trans. at $14.1 per share. 1,270,776
08/12/2021 James R. Meiers
Head of Canada
7,926   Derivative/Non-derivative trans. at $14.1 per share. 111,756
08/12/2021 Denise Menikheim Faltischek
Chief Strategy Officer
9,163   Derivative/Non-derivative trans. at $14.1 per share. 129,198
08/12/2021 Irwin David Simon
President and CEO; Director
180,251   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 James R. Meiers
Head of Canada
32,548   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 Denise Menikheim Faltischek
Chief Strategy Officer
26,443   Derivative/Non-derivative trans. at $0 per share. 0
08/07/2021 Irwin David Simon
President and CEO; Director
12,926   Derivative/Non-derivative trans. at $14.42 per share. 186,392
08/07/2021 Irwin David Simon
President and CEO; Director
25,852   Derivative/Non-derivative trans. at $0 per share. 0
08/05/2021 Brendan Kennedy
Director
300,000   Disposition at $14.46 per share. 4,338,000
08/04/2021 Brendan Kennedy
Director
300,000   Disposition at $14.08 per share. 4,224,000
07/16/2021 Brendan Kennedy
Director
300,000   Disposition at $14.04 per share. 4,212,000
07/15/2021 Brendan Kennedy
Director
76,289   Disposition at $15.18 per share. 1,158,067
07/15/2021 Brendan Kennedy
Director
223,711   Disposition at $14.5 per share. 3,243,809
06/18/2021 Brendan Kennedy
Director
400,000   Disposition at $17.19 per share. 6,876,000
06/17/2021 Brendan Kennedy
Director
400,000   Disposition at $17.97 per share. 7,188,000
06/03/2021 James R. Meiers
Head of Canada
23,826   Disposition at $19.64 per share. 467,942
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. Tilray Jumps, BlackBerry Gains as Market Slips

    9:56 a.m. Aug. 18, 2021

    - Barron's Online

  2. Tilray stock price target cut to $15 from $17 at Alliance Global Partners

    8:14 a.m. Aug. 18, 2021

    - Tomi Kilgore

  3. Tilray eyes U.S. cannabis market with MedMen move, stock gains

    7:24 a.m. Aug. 18, 2021

    - Jeremy C. Owens

  4. A Giant Fund Scooped Up AMC Stock, Bought More Tilray and Carnival

    6:00 a.m. July 31, 2021

    - Barron's Online

  5. Tilray stock price target cut to $14 from $16 at Stifel Nicolaus

    7:21 a.m. July 30, 2021

    - Tomi Kilgore

  6. Tilray Stock Is Up After Surprise Quarterly Profit

    11:36 a.m. July 28, 2021

    - Barron's Online

  7. Tilray CEO asks shareholders to approve additional share issuance to fund growth initiatives

    7:05 a.m. June 29, 2021

    - Ciara Linnane

  8. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. I Was Right About Cannabis Stocks - Now The Future

    9:06 a.m. Sept. 13, 2021

    - Seeking Alpha

  2. Tilray shareholders approve proposal to expand authorized shares

    11:42 a.m. Sept. 10, 2021

    - Seeking Alpha

  3. InterCure: Internationally Profitable Cannabis (Podcast)

    8:30 a.m. Sept. 10, 2021

    - Seeking Alpha

  4. Tilray Stands To Benefit From A Variety Of Factors

    2:04 a.m. Sept. 10, 2021

    - Seeking Alpha

  5. 2 Robinhood Stocks With Market-Beating Potential

    7:20 a.m. Sept. 8, 2021

    - Motley Fool

  6. Tilray: 250 Million Reasons Shareholders Aren't Happy

    11:36 p.m. Sept. 7, 2021

    - Seeking Alpha

  7. 1 Stock I'd Avoid at All Costs

    7:19 a.m. Sept. 5, 2021

    - Motley Fool

  8. Why Tilray, Canopy Growth, and Hexo Stock Rose Today

    4:26 p.m. Sept. 2, 2021

    - Motley Fool

  9. Loading more headlines...

At a Glance

Tilray, Inc.

655 Madison Avenue

19th floor

New York, New York 10065

Phone

1 5193228800

Industry

Farming

Sector

Agriculture

Fiscal Year-end

05/2022

Revenue

$513.09M

Net Income

$-367.42M

2021 Sales Growth

207.3%

Employees

2,100

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Good Stocks To Buy Today? 5 Leisure Stocks In Focus

    2:42 p.m. July 28, 2021

    - StockMarket.com

  2. Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results

    7:00 a.m. July 28, 2021

    - BusinessWire - BZX

  3. Best Marijuana Stocks To Buy In 2021? 4 For Your Watchlist

    10:30 p.m. July 20, 2021

    - StockMarket.com

  4. Top Weed Stocks To Watch Today? 3 For Your Watchlist

    9:03 a.m. July 16, 2021

    - StockMarket.com

  5. High Tide and Halo Announce Closing of Sale of KushBar Assets to Halo

    7:41 a.m. July 15, 2021

    - PR Newswire - PRF

  6. Loading more headlines...
Link to MarketWatch's Slice.